Last reviewed · How we verify

NCT05358496: NAFLD

Study of Neutrophils and Circulating Platelets in Correlation With the Activity of T Lymphocytes in Patients With NAFLD (Nonalcoholic Fatty Liver Disease)

Status unknown Last updated 3 May 2022
What this trial tests

trial testing Data collection in NAFLD- Non Alcoholic Fatty Liver Disease in 80 participants. Status unknown.

Timeline
3 May 2021
Primary endpoint
30 August 2022
30 December 2022

Quick facts

Lead sponsorUniversity of L'Aquila
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment80
Start date3 May 2021
Primary completion30 August 2022
Estimated completion30 December 2022
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of L'Aquila

Who can join

18 and older, any sex, with NAFLD- Non Alcoholic Fatty Liver Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to define the relationship between neutrophils, platelets and the activity of T lymphocytes in patients with NAFLD (nonalcoholic fatty liver disease). This study may predict, in the course of hepatic steatosis, specific phenotypic patterns expressed by PMNs and circulating platelets to evaluate their role in disease progression.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Data collection

Trials testing the same drug.

Other University of L'Aquila trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05358496.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing